Since Baylen Out Loud premiered on TLC in January 2025, Tourette syndrome advocate Baylen Dupree has gained even more social ...

In the renewal announcement clip, Dupree's eyes widen as she reacts, "No! No, really?" She then pumps her fist, flashing the ...

The Phase III DIAMOND trial met both its primary and secondary endpoints of reducing tics in both children and adult patients ...

Ecopipam showed statistical significance in treating Tourette syndrome versus a placebo for both its primary efficacy ...

In the Phase III trial, 41.9% of pediatric Tourette syndrome patients relapsed after ecopipam treatment, as compared with ...

Chicago, USA-based Emalex Biosciences announced positive top-line data from its Phase III registrational study of ecopipam, a ...

The man was arrested after holding a gun to a woman’s head, and no footage of the arrest or the interview show any injury to ...

Baylen Dupree is excited about marking a huge milestone, and her fans are along for the ride. The TLC star got the news on ...

Baylen Out Loud has become a huge hit for TLC, with over 14.7 million views across linear and streaming since its premiere in January, per Variety. The network says Baylen Out Loud is the most-watched ...

Emalex Biosciences said its daily oral tablet helped reduce relapses for children and adults with Tourette syndrome in a ...

Emalex Biosciences’ dopamine blocker led to fewer patients with Tourette syndrome relapsing in a phase 3 trial, setting the ...

Baylen Out Loud star Baylen Dupree has considered undergoing deep brain stimulation as a treatment for her symptoms of ...